Cargando…
Retracted: Effects of Camrelizumab Combined with First-Line Chemotherapy on Serum SCC, VEGF Levels, and Adverse Reactions in Patients with Advanced Squamous Cell Carcinoma of the Lung
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371573/ https://www.ncbi.nlm.nih.gov/pubmed/37502038 http://dx.doi.org/10.1155/2023/9879124 |
| _version_ | 1785078176834125824 |
|---|---|
| author | Intelligence and Neuroscience, Computational |
| author_facet | Intelligence and Neuroscience, Computational |
| author_sort | Intelligence and Neuroscience, Computational |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10371573 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Hindawi |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103715732023-07-27 Retracted: Effects of Camrelizumab Combined with First-Line Chemotherapy on Serum SCC, VEGF Levels, and Adverse Reactions in Patients with Advanced Squamous Cell Carcinoma of the Lung Intelligence and Neuroscience, Computational Comput Intell Neurosci Retraction Hindawi 2023-07-19 /pmc/articles/PMC10371573/ /pubmed/37502038 http://dx.doi.org/10.1155/2023/9879124 Text en Copyright © 2023 Computational Intelligence and Neuroscience. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Retraction Intelligence and Neuroscience, Computational Retracted: Effects of Camrelizumab Combined with First-Line Chemotherapy on Serum SCC, VEGF Levels, and Adverse Reactions in Patients with Advanced Squamous Cell Carcinoma of the Lung |
| title | Retracted: Effects of Camrelizumab Combined with First-Line Chemotherapy on Serum SCC, VEGF Levels, and Adverse Reactions in Patients with Advanced Squamous Cell Carcinoma of the Lung |
| title_full | Retracted: Effects of Camrelizumab Combined with First-Line Chemotherapy on Serum SCC, VEGF Levels, and Adverse Reactions in Patients with Advanced Squamous Cell Carcinoma of the Lung |
| title_fullStr | Retracted: Effects of Camrelizumab Combined with First-Line Chemotherapy on Serum SCC, VEGF Levels, and Adverse Reactions in Patients with Advanced Squamous Cell Carcinoma of the Lung |
| title_full_unstemmed | Retracted: Effects of Camrelizumab Combined with First-Line Chemotherapy on Serum SCC, VEGF Levels, and Adverse Reactions in Patients with Advanced Squamous Cell Carcinoma of the Lung |
| title_short | Retracted: Effects of Camrelizumab Combined with First-Line Chemotherapy on Serum SCC, VEGF Levels, and Adverse Reactions in Patients with Advanced Squamous Cell Carcinoma of the Lung |
| title_sort | retracted: effects of camrelizumab combined with first-line chemotherapy on serum scc, vegf levels, and adverse reactions in patients with advanced squamous cell carcinoma of the lung |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371573/ https://www.ncbi.nlm.nih.gov/pubmed/37502038 http://dx.doi.org/10.1155/2023/9879124 |
| work_keys_str_mv | AT intelligenceandneurosciencecomputational retractedeffectsofcamrelizumabcombinedwithfirstlinechemotherapyonserumsccvegflevelsandadversereactionsinpatientswithadvancedsquamouscellcarcinomaofthelung |